Back to search
FDAFDA · Food and drugs·Recall number D-0085-2018

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

Published November 29, 2017 · Recall initiated: September 28, 2017

Summary

FDA records drug Class II recall D-0085-2018, published November 29, 2017 and initiated September 28, 2017. Recalling firm: Leading Pharma, LLC; Status: Terminated; Reported quantity: 2952 500-count bottles; Lot: Lot #E00717. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

What to do

Voluntary: Firm initiated · Letter

Get an email if LORAZEPAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LORAZEPAM
Manufacturer
Leading Pharma, LLC
Distributor
Nationwide in the USA
UPC
0369315905104
Lot
Lot #E00717
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05 recalled?

Yes. FDA published recall D-0085-2018 on November 29, 2017. Reported hazard: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LORAZEPAM. UPC: 0369315905104.